301 related articles for article (PubMed ID: 33085059)
1. The function and regulation of TET2 in innate immunity and inflammation.
Cong B; Zhang Q; Cao X
Protein Cell; 2021 Mar; 12(3):165-173. PubMed ID: 33085059
[TBL] [Abstract][Full Text] [Related]
2. TET2 as an epigenetic master regulator for normal and malignant hematopoiesis.
Nakajima H; Kunimoto H
Cancer Sci; 2014 Sep; 105(9):1093-9. PubMed ID: 25040794
[TBL] [Abstract][Full Text] [Related]
3. The TET2 interactors and their links to hematological malignancies.
Pan F; Weeks O; Yang FC; Xu M
IUBMB Life; 2015 Jun; 67(6):438-45. PubMed ID: 26099018
[TBL] [Abstract][Full Text] [Related]
4. Tet2 promotes pathogen infection-induced myelopoiesis through mRNA oxidation.
Shen Q; Zhang Q; Shi Y; Shi Q; Jiang Y; Gu Y; Li Z; Li X; Zhao K; Wang C; Li N; Cao X
Nature; 2018 Feb; 554(7690):123-127. PubMed ID: 29364877
[TBL] [Abstract][Full Text] [Related]
5. The methylcytosine dioxygenase Tet2 promotes DNA demethylation and activation of cytokine gene expression in T cells.
Ichiyama K; Chen T; Wang X; Yan X; Kim BS; Tanaka S; Ndiaye-Lobry D; Deng Y; Zou Y; Zheng P; Tian Q; Aifantis I; Wei L; Dong C
Immunity; 2015 Apr; 42(4):613-26. PubMed ID: 25862091
[TBL] [Abstract][Full Text] [Related]
6. TET2 promotes IL-1β expression in J774.1 cell through TLR4/MAPK signaling pathway with demethylation of TAB2 promoter.
Liang Y; Zeng J; Luo B; Li W; He Y; Zhao W; Hu N; Jiang N; Luo Y; Xian Y; Liu J; Zheng X
Mol Immunol; 2020 Oct; 126():136-142. PubMed ID: 32823238
[TBL] [Abstract][Full Text] [Related]
7. TET proteins and 5-methylcytosine oxidation in hematological cancers.
Ko M; An J; Pastor WA; Koralov SB; Rajewsky K; Rao A
Immunol Rev; 2015 Jan; 263(1):6-21. PubMed ID: 25510268
[TBL] [Abstract][Full Text] [Related]
8. Tet2 at the interface between cancer and immunity.
Jiang S
Commun Biol; 2020 Nov; 3(1):667. PubMed ID: 33184433
[TBL] [Abstract][Full Text] [Related]
9. TET2 in Normal and Malignant Hematopoiesis.
Bowman RL; Levine RL
Cold Spring Harb Perspect Med; 2017 Aug; 7(8):. PubMed ID: 28242787
[TBL] [Abstract][Full Text] [Related]
10. DNA methylcytosine dioxygenase ten-eleven translocation 2 enhances lipopolysaccharide-induced cytokine expression in human dental pulp cells by regulating MyD88 hydroxymethylation.
Wang X; Feng Z; Li Q; Yi B; Xu Q
Cell Tissue Res; 2018 Aug; 373(2):477-485. PubMed ID: 29654353
[TBL] [Abstract][Full Text] [Related]
11. TET2: A Novel Epigenetic Regulator and Potential Intervention Target for Atherosclerosis.
Liu Y; Peng W; Qu K; Lin X; Zeng Z; Chen J; Wei D; Wang Z
DNA Cell Biol; 2018 Jun; 37(6):517-523. PubMed ID: 29653065
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic Function of TET Family, 5-Methylcytosine, and 5-Hydroxymethylcytosine in Hematologic Malignancies.
Li W; Xu L
Oncol Res Treat; 2019; 42(6):309-318. PubMed ID: 31055566
[TBL] [Abstract][Full Text] [Related]
13. Dysregulation of TET2 in hematologic malignancies.
Chiba S
Int J Hematol; 2017 Jan; 105(1):17-22. PubMed ID: 27848178
[TBL] [Abstract][Full Text] [Related]
14. [TET2 gene in hematological diseases].
Li S; Wang XQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):836-41. PubMed ID: 24989305
[TBL] [Abstract][Full Text] [Related]
15. MBD3L2 promotes Tet2 enzymatic activity for mediating 5-methylcytosine oxidation.
Peng L; Li Y; Xi Y; Li W; Li J; Lv R; Zhang L; Zou Q; Dong S; Luo H; Wu F; Yu W
J Cell Sci; 2016 Mar; 129(5):1059-71. PubMed ID: 26769901
[TBL] [Abstract][Full Text] [Related]
16. [TET2 as a gatekeeper for hematologic malignancies].
Muto H; Sakata-Yanagimoto M; Chiba S
Rinsho Ketsueki; 2015 Jun; 56(6):651-6. PubMed ID: 26256875
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic silencing of TET2 and TET3 induces an EMT-like process in melanoma.
Gong F; Guo Y; Niu Y; Jin J; Zhang X; Shi X; Zhang L; Li R; Chen L; Ma RZ
Oncotarget; 2017 Jan; 8(1):315-328. PubMed ID: 27852070
[TBL] [Abstract][Full Text] [Related]
18. Association of high 5-hydroxymethylcytosine levels with Ten Eleven Translocation 2 overexpression and inflammation in Sjögren's syndrome patients.
Lagos C; Carvajal P; Castro I; Jara D; González S; Aguilera S; Barrera MJ; Quest AFG; Bahamondes V; Molina C; Urzúa U; Hermoso MA; Leyton C; González MJ
Clin Immunol; 2018 Nov; 196():85-96. PubMed ID: 29894742
[TBL] [Abstract][Full Text] [Related]
19. The Ten-Eleven Translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases.
Solary E; Bernard OA; Tefferi A; Fuks F; Vainchenker W
Leukemia; 2014 Mar; 28(3):485-96. PubMed ID: 24220273
[TBL] [Abstract][Full Text] [Related]
20. Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6.
Zhang Q; Zhao K; Shen Q; Han Y; Gu Y; Li X; Zhao D; Liu Y; Wang C; Zhang X; Su X; Liu J; Ge W; Levine RL; Li N; Cao X
Nature; 2015 Sep; 525(7569):389-393. PubMed ID: 26287468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]